bg-clinical-hero
vector-clinical-hero

Imagene for Clinical

Mask Group
Mask Group-2

As the pursue of better patient healthcare continues, medical centers seek novel innovative technologies that can help reduce errors and increase standardization, leading ultimately to best treatment decisions for each patient.

Current patient diagnosis processes fail to identify all biomarkers, most are not tested in the standard of care. This is due to the dependence on adequate tissue to deliver conclusive results, and the costly and cumbersome process involved.

lmagene delivers a game-changing approach to oncology patient healthcare

lmagene's solution detects, with high sensitivity and specificity, a broad range of biomarkers, enabling a better diagnosis for cancer patients and providing real-time identification of candidates for clinical trials and for targeted cancer therapy, and all of this using a biopsy image only

clinical-infographic
bg-clinical-infographic
Benefits
icon-clinical-benefits-1

Real-time Diagnosis

icon-clinical-benefits-2

Image Only (no tissue required)

icon-clinical-benefits-3

Accuracy levels of diagnostic tests

icon-clinical-benefits-4

Optimized treatment plans